κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction
Authors:
- Vadim YuferovVYVadim Yuferov
- Mary Jeanne KreekMKMary Jeanne Kreek
- 1 October 2012
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 35 (10) , 587-596
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: A reviewDrug and Alcohol Dependence, 2011
- Kappa Opioid Receptor Signaling in the Basolateral Amygdala Regulates Conditioned Fear and Anxiety in RatsBiological Psychiatry, 2011
- Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptorsBioorganic & Medicinal Chemistry, 2011
- The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abusePsychopharmacology, 2010
- The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviorsBrain Research, 2010
- Syntheses of novel high affinity ligands for opioid receptorsBioorganic & Medicinal Chemistry Letters, 2009
- Epigenetic regulation of kappa opioid receptor gene in neuronal differentiationNeuroscience, 2007
- Central κ-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: Behavioral and BDNF mRNA expression studiesEuropean Journal of Pharmacology, 2007
- Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodynEuropean Journal of Pharmacology, 2007
- κ-Opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administrationNeuropharmacology, 2006